Financing ·
Evogene Ltd. entered into a Sales Agreement with A.G.P./Alliance Global Partners on June 11, 2026, to facilitate an…
EVGNEvogene Ltd.
Evogene Ltd. entered into a Sales Agreement with A.G.P./Alliance Global Partners on June 11, 2026, to facilitate an "at the market" (ATM) offering of its ordinary shares for an aggregate offering price of up to $2,926,500. The Agent will sell shares via privately negotiated transactions or through the Nasdaq Stock Market. Evogene Ltd. is a biotechnology company focused on on-demand plant and crop science solutions.